Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis

Eur Respir J. 2018 Apr 4;51(4):1702127. doi: 10.1183/13993003.02127-2017. Print 2018 Apr.

Authors

John P Scott¹, Yinduo Ji², Mathur Kannan², Mark E Wylam³

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
² Dept of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN, USA.
³ Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA [email protected].

PMID: 29419443
DOI: 10.1183/13993003.02127-2017

No abstract available

Publication types

Case Reports
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Child
Cystic Fibrosis / microbiology*
Cystic Fibrosis / physiopathology
Female
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage*
Humans
Lung / physiopathology*
Male
Mycobacterium Infections / complications
Mycobacterium Infections / drug therapy*
Mycobacterium abscessus
Respiratory Function Tests

Substances

Granulocyte-Macrophage Colony-Stimulating Factor